Advertisement
Loading...

Quest Diagnostics Incorporated

DGX•NYSE
Healthcare
Medical - Diagnostics & Research
$186.61
$-1.33(-0.71%)
U.S. Market opens in 37h 53m

Quest Diagnostics Incorporated (DGX) Stock Overview

Explore Quest Diagnostics Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap20.7B
P/E Ratio20.11
EPS (TTM)$9.05
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$199.87
3 Months$202.30
1 Year Target$186.36

DGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Quest Diagnostics Incorporated (DGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.20, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $186.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.11 and a market capitalization of 20.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.71%
5-Day Change
-2.67%
1-Month Change
-2.52%
3-Month Change
-9.80%
6-Month Change
-0.19%
Year-to-Date (YTD) Change
7.53%
1-Year Change
5.78%
3-Year Change
40.94%
5-Year Change
41.35%
All-Time (Max) Change
5231.43%

Contact Information

https://www.questdiagnostics.com
973 520 2700
500 Plaza Drive, Secaucus, NJ, 07094

Company Facts

55,000 Employees
IPO DateDec 17, 1996
CountryUS
Actively Trading

Frequently Asked Questions